ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q3Scopus Q2SCImago #6,983Gold OA

Therapeutic Advances in Ophthalmology

Identifier (ISSN):2515-8414(Print)
•
Publisher:SAGE Publishing
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
2↓ -0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Therapeutic Advances in Ophthalmology

WoS Q3
12342.520232.320242.3202522026
Annual Impact Factor Metric
Current (2026):2
Scopus SJR & RankScopus Q2
0.795
#6,983

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
26

26 papers with at least that number of citations each

WoS: ESCIQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
64articles/year
100% Gold OA•65.91% Original Research

Aims & Scope

Therapeutic Advances in Ophthalmology (ISSN: 2515-8414) is a peer-reviewed international scholarly journal in the field of OPHTHALMOLOGY, published by SAGE Publishing in United Kingdom. The periodical holds a Journal Impact Factor (JIF) of 2.00, ranking in quartile Q3 of Web of Science (ESCI), a Scopus SJR indicator of 0.795 (Q2), an H-index of 26.

Topics Covered (Recognized by AI)
Medicine95.8%Biology87%Ophthalmology82.4%Surgery72.8%Physics69%Optics66.1%Internal medicine65.7%Psychology63.6%Chemistry48.1%Pathology47.7%Biochemistry45.2%Neuroscience44.4%Visual acuity43.9%Psychiatry38.5%Botany33.5%Retinal32.6%Radiology32.6%Genetics31.4%Endocrinology24.7%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

OPHTHALMOLOGY

Q3
Rank55/98
IndexESCI
JCIESCI2026

OPHTHALMOLOGY

Q2
Rank48/98
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

9 year
2026Latest
IF2
Articles / Year32
Total Citations2
2025
IF2.3
Articles / Year51
Total Citations51
2024
IF2.3
Articles / Year21
Total Citations88
2023
IF2.5
Articles / Year35
Total Citations126
2022
IF—
Articles / Year46
Total Citations496

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,983Scopus Q2SCImago Profile
Scopus Coverage:2018-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.795

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.07

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,256 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations257
3-Year Documents100
Citable Documents97

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate36.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OphthalmologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区OPHTHALMOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Therapeutic Advances in Ophthalmology (ISSN: 2515-8414) is a peer-reviewed international scholarly journal in the field of OPHTHALMOLOGY, published by SAGE Publishing in United Kingdom. The periodical holds a Journal Impact Factor (JIF) of 2.00, ranking in quartile Q3 of Web of Science (ESCI), a Scopus SJR indicator of 0.795 (Q2), an H-index of 26.

The journal enforces rigorous peer evaluation with an annual output of approximately 64 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,256 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
SAGE Publishing
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIDOAJPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: e3f416c0-f6d0-44e6-9843-aa4eefe6efd1
Database Updated: 2026-10-01